N-linked glycosylation in C2 region of HIV-1 envelope reduces sensitivity to neutralizing antibodies

Viral Immunology

Volumn 18, Issue 2, 2005, Pages 343-353

  Teeraputon, Sirilak ^a,b   Louisirirojchanakul, Suda ^a   Auewarakul, Prasert ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b NARESUAN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLYCAN; GLYCOPROTEIN GP 120; NEUTRALIZING ANTIBODY;

ANTIBODY RESPONSE; ARTICLE; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PHENOTYPE; VIRUS ENVELOPE; VIRUS NEUTRALIZATION; VIRUS RESISTANCE; VIRUS STRAIN;

AMINO ACID SEQUENCE; CELL LINE; FEMALE; GLYCOSYLATION; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PEPTIDE FRAGMENTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 23344435219     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2005.18.343     Document Type: Article

References (38)

1. Auewarakul, P., S. Louisirirotchanakul, R. Sutthen, et al. 1996. Analysis of neutralizing and enhancing antibodies to human immunodeficiency virus type 1 primary isolates in plasma of individuals infected with env Genetic subtype B and E viruses in Thailand. Viral Immunol. 9:175-185.
2. Auewarakul, P., V. Paungcharoen, S. Louisirirotchanakul, et al. 2001. Application of HIV-1-green fluorescent protein (GFP) reporter viruses in neutralizing antibody assays. Asian Pac. J. Allergy Immunol. 19:139-144.
3. Cavacini, L.A., C.L. Emes, J. Power, et al. 1993. Human monoclonal antibodies to the V3 loop of HIV-1 gp120 mediate variable and distinct effects on binding and viral neutralization by a human monoclonal antibody to the CD4 binding site. J. Acquir. Immune Defic. Syndr. 64:353-358.
4. Cecilia, D., V.N. KewalRamani, J. O'Leary, et al. 1998. Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage. J. Virol. 72:6988-6996.
5. Conley, A.J., M.K. Gorny, J.A. Kessler 2nd, et al. 1994. Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D. J. Virol. 68:6994-7000.
6. Evans, D.J., J. McKeating, J.M. Meredith, et al. 1989. An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies. Nature 339:385-388.
7. Gao, F., L. Yue, S. Craig, et al. 1994. Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtype A, B, C, and E. AIDS Res. Hum. Retroviruses 10:1359-1368.
8. Gao, F., S.G. Morrison, D.L. Robertson, et al. 1996. Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. J Virol. 70:1651-1667.
9. Gorny, M.K., A.J. Conley, S. Karwowska, et al. 1992. Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody. J. Virol. 66:7538-7542.
10. Gorny, M.K., J.Y. Xu, S. Karwowska, et al. 1993. Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120. J. Immunol. 1502: 635-643.
11. Gorny, M.K., T.C. VanCott, C. Hioe, et al. 1997. Human monoclonal antibodies to the V3 loop of HIV-1 with intra- and interclade cross-reactivity. J. Immunol. 159:5114-5122.
12. Gram, G.J., A. Hemming, A. Bolmstedt, et al. 1994. Identification of an N-linked glycan in the V1-loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4. Arch. Virol. 139:243-61.
13. Koch, M., M. Pancera, P.D. Kwong, et al. 2003. Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition. Virology 313:387-400.
14. Kwong, P.D., R. Wyatt, J. Robinson, et al. 1998. Structure of an HIV gp120 envelop glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393:648-659.
15. Kwong, P.D., R. Wyatt, E. Desjardins, et al. 1999. Probability analysis of variational crystallization and its application to gp120, the exterior envelope glycoprotein of type 1 human immunodeficiency virus (HIV-1). J. Biol. Chem. 274:4115-4123.
16. Kwong, P.D., M.L. Doyle, D.J. Casper, et al. 2002. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 420: 678-682.
17. Lee, W.R., W.J. Syu, B. Du, et al. 1992. Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 89:2213-2217.
18. Leonard, C.K., M.W. Spellman, L. Riddle, et al. 1990. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in chinese hamster ovary cells. J. Biol. Chem. 265:10373-10382.
19. Louisirirotchanakul, S., S. Beddows, R. Cheingsong, et al. 1999. Role of maternal humoral immunity in vertical transmission of HIV-1 subtype E in Thailand. J. Acquir. Immune Defic. Syndr. 21:259-265.
20. Louwagie, J., W. Janssens, J. Mascola, et al. 1995. Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J. Virol. 69:236-271.
21. Malenbaum, S.E., D. Yang, L. Cavacini, et al. 2000. The N-terminal V3 loop glycan modulates the interaction of clade A and B human immunodeficiency virus type 1 envelopes with CD4 and chemokine receptors. J. Virol. 74:11008-11016.
22. McCaffrey, R.A., C. Saunders, M. Hensel, et al. 2004. N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies. J. Virol. 78:3279-3295.
23. Moore, J.P., Y. Cao, L. Qing, et al. 1995. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. J. Virol. 69:101-109.
24. Nakayama, E.E., T. Shioda, M. Tatsumi, et al. 1998. Importance of the N-glycan in the V3 loop of HIV-1 envelope protein for CXCR-4- but not CCR-5-dependent fusion. FEBS Lett. 426:367-372.
25. Nyambi, P.N., M.K. Gorny, L. Bastiani, et al. 1998. Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1. J. Virol. 7211:9384-9391.
26. Parren, P.W., J.P. Moore, D.R. Burton, et al. 1999. The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity. AIDS 13(Suppl A):S137-S162.
27. Polonis, V.R., M.S. De Souza, P. Chanbancherd, et al. 2001. HIV type 1 subtype E-infected patients with broadened, dual (B/E) V3 loop serology have increased cross-neutralizing antibodies. AIDS Res. Hum. Retroviruses 17:69-79.
28. Polzer, S., M.T. Dittmar, H. Schmitz, et al. 2002. The N-linked glycan g15 within the V3 loop of the HIV-1 external glycoprotein gp120 affects coreceptor usage, cellular tropism, and neutralization. Virology 304:70-80.
29. Posner, M.R., T. Hideshima, T. Cannon, et al. 1991. An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection. J. Immunol. 146:4325-4332.
30. Posner, M.R., L.A. Cavacini, C.L. Emes, et al. 1993. Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120. J. Acquir. Immune. Defic. Syndr. 6:7-14.
31. Quinones-Kochs, M.I., L. Buonocore, J.K. Rose. 2002. Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response. J. Virol. 76:4199-4211.
32. Si, Z., M. Cayabyab, J. Sodroski. 2001. Envelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys. J. Virol. 75:4208-4218.
33. Sullivan, N., Y. Sun, Q. Sattentau, et al. 1998. CD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization. J. Virol. 726:4694-4703.
34. Wei, X., J.M. Decker, S. Wang, et al. 2003. Antibody neutralization and escape by HIV-1. Nature 22:307-312.
35. Willey, R., R. Rutledge, D. Dias, et al. 1986. Identification of conserved and divergent domains within the envelope gene: of the acquired immunodeficiency syndrome retrovirus. Proc. Natl. Acad. Sci. U.S.A. 83:5038-5042.
36. Wyatt, R., J. Sodroski. 1998. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280:1884-1888.
37. Wyatt, R., P.D. Kwong, E. Desjardins, et al. 1998. The antigenic structure of an HIV gp120 envelope glycoprotein. Nature 393:705-711.
38. Zolla-Pazner, S., J. O'Leary, S. Burda, et al. 1995. Serotyping of primary human immunodeficiency virus type 1 isolates from diverse geographic locations by flow cytometry. J. Virol. 696:3807-3815.